Michael Kassiou

@MichaelKassiou

Professor of Medicinal Chemistry at the University of Sydney. Research in CNS, drug discovery, and medicinal chemistry @Sydney_Uni

Joined August 2016

89 Following 520 Followers 881 Posts

Latest posts 5

Michael Kassiou @MichaelKassiou Jun 7, 2024

It has been a pleasure having you here for 8 years. I’m sure you will continue to excel.

Kassiou Group @KassiouGroup Jun 7, 2024

Celebrating Alison’s 8 year tenure in the Kassiou Group before she jets off to London!

You have had a huge impact on the group, thankyou for all your work and good luck!

View quoted post on X

Michael Kassiou @MichaelKassiou Sep 27, 2023

Great to spend the day catching up with my good friend, Professor TSPO himself, Vassilios Papadopoulos. #TSPO @Sydney_Uni @Sydney_Science @Sydney_DDI @KassiouGroup @TitchDanon

Michael Kassiou @MichaelKassiou Jul 19, 2023

Honoured and thrilled to be a @eurekaprizes finalist for Leadership in Science and Innovation.
Grateful for the recognition and best of luck to all the finalist. Looking forward to the celebration.
#EurekaPrizes #LeadershipForGood #USYD #DDI #SydneyScience #SydneyChemistry

Australian Museum Eureka Prizes @eurekaprizes Jul 19, 2023

Professor Michael Kassiou @Sydney_Uni is a finalist in the Eureka Prize for Leadership in Science and Innovation.

Learn more: youtu.be/3YqsaXDOAFk

#EurekaPrizes

View quoted post on X

Michael Kassiou @MichaelKassiou May 4, 2023

The reward for me has been working with a stellar team of scientist which started with @willJorgo 10yrs ago, Dr Katte, @KiyanAfzali, @tristanreekie, Dr Werry including many others.

‘Think of it like Lego’: The Sydney chemist who found a $273m molecule smh.com.au/national/nsw/t…

www.smh.com.au A Sydney chemist hunted this molecule for a decade. Now it’s worth $273 million Chemicals that replicate the body’s “love drug” could be key to treating dementia, depression and schizophrenia.

Michael Kassiou @MichaelKassiou Nov 8, 2021

Great to see the paper with Alexandra Maximova and Eryn L. Werry on #Senolytics: A Novel Strategy for #Neuroprotection in #ALS? out today. mdpi.com/1349038 #mdpiijms via @IJMS_MDPI

@JNNP_BMJ @Sydney_DDI @sydFMH_EMCR @Sydney_Science @SydneyChemistry

www.mdpi.com Senolytics: A Novel Strategy for Neuroprotection in ALS? Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegenerative disease that currently has no cure and has few effective treatments. On a cellular level, ALS manifests through signific...